# Do No Harm

Type: advocacy group

Source: Biotech Intelligence Brief — https://getbiobrief.com/entity/do-no-harm
Canonical HTML page: https://getbiobrief.com/entity/do-no-harm

## Recent coverage (1 stories)

### Do No Harm: 0 High-Certainty Studies Support Pediatric Gender Drugs
2026-06-12 00:41:29 · Sentiment: Bearish · Impact: 6/10 · Sources: 8

Biopharma companies face a potentially shrinking market and tougher FDA standards after Senate testimony highlighted 'very low certainty evidence' for pediatric gender treatments. With systematic reviews failing to show robust benefit, pipeline programs and commercial prospects for puberty blockers and cross-sex hormones are at risk.
Full story: https://getbiobrief.com/story/do-no-harm-0-high-certainty-evidence-bio

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getbiobrief.com/guides/methodology for the full editorial methodology.